Back
ESC Professional Premium Access

Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: a nationwide cohort study

Session: Anticoagulant therapy: real world use and clinical challenges
Topic: Anticoagulants
Speaker: Mr M. Grymonprez (Gent, BE)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Mr Maxim Grymonprez

University Hospital Ghent, Gent (Belgium)
0 follower

4 more presentations in this session

Oral anticoagulation in patients with atrial fibrillation and stage IV and V chronic kidney disease: a systematic review and meta-analysis

Speaker: Doctor A. Miranda-Arboleda (Boston, US)

Access
Abstract
Slides
Like
Thumbnail

The real-world effectiveness and safety of edoxaban treatment in 27,333 Global ETNA-AF programme patients with and without a history of heart failure

Speaker: Professor J. Siller-Matula (Vienna, AT)

Access
Abstract
Slides
Like
Thumbnail

Potentially inappropriate prescribing and its demographic and clinical correlates in older adults with atrial fibrillation: a population-based study

Speaker: Ms C. Amrouch (Ghent, BE)

Access
Abstract
Slides
Like
Thumbnail

The effect of eplerenone on the disease onset and progression of phospholamban cardiomyopathy in presymptomatic mutation carriers: results of the i-PHORECAST trial

Speaker: Mr R. De Brouwer (Groningen, NL)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Anticoagulant therapy: real world use and clinical challenges

Speakers: Mr M. Grymonprez, Doctor A. Miranda-Arboleda, Professor J. Siller-Matula, Ms C. Amrouch, Mr R. De Brouwer
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources